These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6072449)
1. The medical-legal aspects of adverse drug reactions. Tozer FL; Kasik JE Clin Pharmacol Ther; 1967; 8(5):637-46. PubMed ID: 6072449 [No Abstract] [Full Text] [Related]
2. The case for deregulating drug efficacy. Dorsey R JAMA; 1979 Oct; 242(16):1755-60. PubMed ID: 480602 [No Abstract] [Full Text] [Related]
3. Compensation for drug injury. Problems both sides of the Atlantic. Smith R Br Med J (Clin Res Ed); 1981 May; 282(6274):1443-5. PubMed ID: 6784859 [No Abstract] [Full Text] [Related]
4. The role of litigation in defining drug risks. Kesselheim AS; Avorn J JAMA; 2007 Jan; 297(3):308-11. PubMed ID: 17227983 [No Abstract] [Full Text] [Related]
5. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
6. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
7. Legal pitfalls and the medical practitioner. Marnham SR S Afr Med J; 1975 Jun; 49(27):1104. PubMed ID: 1154162 [No Abstract] [Full Text] [Related]
8. Legal restrictions on compounding. Geyer RE J Am Vet Med Assoc; 1994 Jul; 205(2):241-2. PubMed ID: 7928588 [No Abstract] [Full Text] [Related]
14. Nutraceuticals. Curry M; Hazard-Daniel A; Daniel HJ Science; 1999 Dec; 286(5446):1854-5. PubMed ID: 10610573 [No Abstract] [Full Text] [Related]
15. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission. Joffe S; Lynch HF N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302 [No Abstract] [Full Text] [Related]
16. Legal problems in psychiatric drug prescription. Appleton WS Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683 [No Abstract] [Full Text] [Related]
17. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health. Gostin LO JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642 [No Abstract] [Full Text] [Related]
18. Generally Regarded As Safe. Novack GD Ocul Surf; 2017 Jan; 15(1):152-155. PubMed ID: 27871773 [No Abstract] [Full Text] [Related]
19. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels. Boumil MM; Curfman G JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167 [No Abstract] [Full Text] [Related]
20. Addressing Pharmaceutical Injuries: The US Landscape. Bakker C; Honig N Clin Pharmacol Ther; 2018 Mar; 103(3):384-385. PubMed ID: 28850676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]